Blumenthal Cancer Center/Carolinas Medical Center

Charlotte, North Carolina 28204

0 studies enrolling now · 3 studies all time

What they study most

Advanced Melanoma, Melanoma, Metastatic Renal Cell Cancer

Studies at this site

• Phase II, 2nd Line Melanoma - RAND Monotherapy — Completed
• Drug-Drug Interaction - 3 Arm - Carboplatin/Paclitaxel, Dacarbazine — Completed
• Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy — NO_LONGER_AVAILABLE